News

The approval for Biogen’s disease-modifying, anti-amyloid agent aducanumab follows a long regulatory journey.

Using both tests to screen for colorectal cancer was more effective than just using colonoscopies alone.

COVID-19 severity should be looked at in the context of pre-existing comorbidities, age, social determinants, and bias among data sources.

Potential public health benefit of OAT linked to 50% lower risk of all-cause mortality.

The higher levels of visits were mostly maintained throughout the pandemic.

Direct-acting antivirals has increased the need to treat children HCV patients before they begin to engage in dangerous behaviors.

The US is expected to fall just short of the goal of having 70% of adults vaccinated by July 4.

The new indication for the therapy provides coverage for patients with the rare blood disease as young as 1 month old.

Misha Rosenbach, MD, gives an overview of climate change and its relevance to dermatology.

Data show 1 in 5 surgical patients who receive prescriptions for benzodiazepine go on to use them persistently.

Externalizing ADHD symptoms was linked to suicidality.

Vedolizumab treatment was associated with lower IMC recurrence rate after ICI resumption.

There are no guidelines on sickle cell patient referral to pulmonologists, associated outcomes, and best therapeutic interventions.

Jordana Hoppe, MD, highlights some key points about the genetic condition.

The reduction in heavy drinking in individuals between 18-25 years old is likely due to government restrictions on social gatherings.

The indication makes the Novo Nordisk product the first weekly injection GLP-1 agonist approved for managing overweight and obesity.

Data show HDP occurred in 7.4% of pregnancies in France during the study period.

A recommendation for all adults in the US to be screened for HCV has increased the need for treatment programs in urban areas.

Meaningful change thresholds in POEM and DLQI scores have been established for adolescents and adults.

Medtronic has halted sale of the HeartWare Ventricular Assist Device System after more than 100 complaints were filed, including 14 reports of mortality.

Seres expects to move forward with plans for SER-109 as a novel treatment for CDI.

A panel of retinal experts developed definitions for and classified the reasons behind patient nonadherence and nonpersistence.

Researchers compare 9 commonly used thermal care interventions for reduced core body temperatures.

Resolution of iron deficiency was associated with lower mortality; however, mortality risk was similar following resolution of anemia.

Greater symptoms of depression, anxiety, and ADHD were associated with less sleep.

More patients treated with risankizumab 360 mg achieved clinical remission than the induction-only control group.

There may be an association between atopic dermatitis severity and diagnosis of ocular disease, such as conjunctivitis.

The device is designed to assist in diagnosis to provide early intervention and appropriate care.